Introducing artificial intelligence tools into clinical and non-clinical workflows, Evidence from the NHS Breast Screening Programme of staff and general population perceptions of and trust in the use of AI in this context and the implications for further testing and implementation.

Abstract

Background: The East Midlands Radiology Consortium (EMRAD) is a partnership of seven NHS trusts spread over 11 hospitals, covering more than five million patients in the East Midlands of England. In 2018, EMRAD formed a partnership with two UK-based Artificial Intelligence (AI) companies, Faculty and Kheiron Medical, to help develop, test and - ultimately - deploy AI tools in the breast cancer screening programme in the East Midlands as part of wave two NHS Test Beds programme. The project aims to improve and optimise clinical service capacity, to enhance patient care at significant scale and to increase NHS confidence in the utilisation of innovative machine learning tools. The successful implementation of the technology rests not only on its clinical effectiveness but also on the attitudes of key adopters and organisational readiness (Greenhalgh et al, 2017).